FB Pixel no scriptMedtech | KrASIA
MENU
KrASIA

Medtech

Insights

Dingdang Health and the volatile pharmaceutical O2O industry (Part 1 of 2)

After a shaky start, Dingdang Health has finally started to see some measure of success. But will new competitors in the arena threaten its position?

3 mins read
  • Zheng explains the obligation to improve patients’ lives over the course of decades.

    Q&A

    Hearing it all: Q&A with Amy Zheng, Asian growth markets general manager of Cochlear

    7 mins read

Most Recent

See All